In colorectal cancer, H19 promotes cancer cell stemness and resistance to oxaliplatin by acting as a ceRNA that mute miR-141, a microRNA known to suppress cancer stemness by targeting the β-catenin to block the WNT/β-catenin pathway [60]. Here, H19 is linked to colorectal cancer.